Target Discovery, Inc.

Organization Address
4030 Fabian Way
Palo Alto, CA 94303-4607

Organization Phone



Organization Description
Target Discovery discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and management of disease. A growing body of scientific literature shows that protein isoforms correlate more precisely with disease state and patient-specific treatment response than current clinical biomarkers. Most protein isoforms (90%) are made by the body after the protein is produced (post-translational modifications). Such protein modifications remain largely inaccessible to current immunodiagnostic and nucleic acid clinical assays. Target Discovery's Isonostic? products are designed to make this isoform biomarker information accessible to clinicians.

Clinical Development Stage